Antihypertensive treatment in mild hypertension, its problems and future trends.
作者信息
Widimský J
机构信息
Department of Cardiology, Institute for Postgraduate Medical Education, Prague, Czechoslovakia.
出版信息
Cor Vasa. 1987;29(4 Suppl 1):1-10.
PMID:3315445
Abstract
摘要
相似文献
1
Antihypertensive treatment in mild hypertension, its problems and future trends.轻度高血压的降压治疗、存在的问题及未来趋势。
Cor Vasa. 1987;29(4 Suppl 1):1-10.
2
[Improvement of the functional capacity of hypertensive patients treated with guanfacine].[使用胍法辛治疗的高血压患者功能能力的改善]
Cas Lek Cesk. 1986 May 23;125(21):637-40.
3
Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Neth J Med. 1987 Aug;31(1-2):58-65.
4
[Treatment of arterial hypertension with a single daily dose of guanfacine].
Arq Bras Cardiol. 1984 Nov;43(5):365-9.
5
[Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Med Welt. 1983 Feb 4;34(5):158-61.
6
Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.胍法辛与甲基多巴的降压活性及耐受性比较。
Int J Clin Pharmacol Res. 1983;3(1):35-9.
7
Guanfacine: a new centrally-acting antihypertensive agent.
Pharmatherapeutica. 1981;2(8):513-6.
8
Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).用胍法辛（桑多斯公司的埃斯图利克）治疗的高血压患者运动表现得到改善。
Cor Vasa. 1987;29(4 Suppl 1):42-5.
9
Guanfacine (Estulic) in the treatment of hypertension.胍法辛（埃斯妥立）治疗高血压
Cor Vasa. 1987;29(4 Suppl 1):1-52.
Zotero 插件